DUET-102

N/A

Report date: 2025/06/11 10:32:14
NME

Base Information

Drug NameDUET-102
Drug Alias NameCpG-STAT3-dsASO
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitorsAntisense oligonucleotide inhibitorsToll like receptor 9 agonists
TargetsSignal transducer and activator of transcription 3Toll like receptor 9
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCity of Hope
China Registration ClassN/A

Develop Information

Active CompaniesDuet BioTherapeutics IncCity of HopeNorthwestern University
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A